Rep. Lisa C. McClain Buys Globe Life Inc. (NYSE:GL) Stock

Key Points

• Representative Lisa C. McClain purchased between $1,001 and $15,000 in shares of Globe Life Inc. (NYSE: GL) on June 17th, as disclosed in a recent filing.
• Globe Life announced a quarterly dividend of $0.27, which will be paid on October 31st, with an ex-dividend date of October 3rd, representing an annualized dividend yield of 0.8%.
• Wells Fargo and JPMorgan have recently increased their price targets for Globe Life shares, now set at up to $160.00, with multiple analysts rating the stock as a "buy".

Representative Lisa C. McClain (R-Michigan) recently bought shares of Globe Life Inc. NYSE: GL. In a filing disclosed on August 13th, the Representative disclosed that they had bought between $1,001 and $15,000 in Globe Life stock on June 17th. The trade occurred in the Representative's "CHARLES SCHWAB BROKERAGE ACCOUNT 924" account.

Representative Lisa C. McClain also recently made the following trade(s):

• Sold $1,001 - $15,000 in shares of Autoliv NYSE: ALV on 8/4/2025.
• Sold $1,001 - $15,000 in shares of Amazon.com NASDAQ: AMZN on 8/4/2025.
• Sold $1,001 - $15,000 in shares of Applied Materials NASDAQ: AMAT on 8/4/2025.
• Sold $1,001 - $15,000 in shares of Arthur J. Gallagher & Co. NYSE: AJG on 8/4/2025.
• Sold $1,001 - $15,000 in shares of SAP NYSE: SAP on 7/22/2025.
• Purchased $1,001 - $15,000 in shares of XPO NYSE: XPO on 7/22/2025.
• Purchased $1,001 - $15,000 in shares of Lithia Motors NYSE: LAD on 7/22/2025.
• Sold $1,001 - $15,000 in shares of Sanofi NASDAQ: SNY on 7/22/2025.
• Sold $1,001 - $15,000 in shares of Waters NYSE: WAT on 7/22/2025.
• Purchased $1,001 - $15,000 in shares of Group 1 Automotive NYSE: GPI on 7/22/2025.

Globe Life Price Performance

Shares of GL stock traded up $0.33 on Tuesday, reaching $139.72. 538,447 shares of the company were exchanged, compared to its average volume of 694,883. The company has a market cap of $11.32 billion, a price-to-earnings ratio of 11.17 and a beta of 0.56. The business has a 50-day moving average price of $129.59 and a 200 day moving average price of $125.13. The company has a debt-to-equity ratio of 0.43, a quick ratio of 0.06 and a current ratio of 0.06. Globe Life Inc. has a 1 year low of $99.04 and a 1 year high of $144.00.

Globe Life (NYSE:GL - Get Free Report) last released its earnings results on Wednesday, July 23rd. The company reported $3.27 EPS for the quarter, topping analysts' consensus estimates of $3.25 by $0.02. The business had revenue of $1.48 billion during the quarter, compared to analysts' expectations of $1.50 billion. Globe Life had a net margin of 18.11% and a return on equity of 21.24%. The company's quarterly revenue was up 2.9% on a year-over-year basis. During the same quarter in the previous year, the company earned $2.97 earnings per share. Globe Life has set its FY 2025 guidance at 14.250-14.650 EPS. Equities research analysts forecast that Globe Life Inc. will post 13.87 earnings per share for the current fiscal year.

Globe Life Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Friday, October 3rd will be paid a dividend of $0.27 per share. The ex-dividend date of this dividend is Friday, October 3rd. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.8%. Globe Life's payout ratio is currently 8.63%.

Analyst Upgrades and Downgrades

A number of analysts have recently commented on GL shares. BMO Capital Markets reissued a "market perform" rating and set a $149.00 target price (up previously from $114.00) on shares of Globe Life in a research note on Wednesday, July 30th. Morgan Stanley boosted their target price on shares of Globe Life from $166.00 to $171.00 and gave the stock an "overweight" rating in a research note on Monday, August 18th. JPMorgan Chase & Co. boosted their target price on shares of Globe Life from $145.00 to $160.00 and gave the stock an "overweight" rating in a research note on Tuesday, July 8th. Keefe, Bruyette & Woods upped their price objective on shares of Globe Life from $145.00 to $155.00 and gave the company an "outperform" rating in a research note on Monday, July 28th. Finally, Wall Street Zen raised shares of Globe Life from a "hold" rating to a "buy" rating in a research note on Friday, May 16th. One equities research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and two have assigned a Hold rating to the company's stock. According to data from MarketBeat.com, Globe Life currently has an average rating of "Moderate Buy" and a consensus target price of $152.45.

Insider Activity at Globe Life

In other Globe Life news, CFO Thomas Peter Kalmbach sold 28,952 shares of Globe Life stock in a transaction on Tuesday, July 29th. The shares were sold at an average price of $140.97, for a total value of $4,081,363.44. Following the transaction, the chief financial officer directly owned 30,665 shares in the company, valued at approximately $4,322,845.05. The trade was a 48.56% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO James Matthew Darden sold 33,270 shares of Globe Life stock in a transaction on Friday, July 25th. The shares were sold at an average price of $135.59, for a total transaction of $4,511,079.30. Following the completion of the transaction, the chief executive officer owned 49,842 shares in the company, valued at approximately $6,758,076.78. This represents a 40.03% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 84,722 shares of company stock valued at $11,733,793 over the last quarter. 1.97% of the stock is owned by insiders.

Institutional Trading of Globe Life

Hedge funds have recently made changes to their positions in the company. Global Assets Advisory LLC purchased a new stake in shares of Globe Life in the 2nd quarter valued at approximately $25,000. AdvisorNet Financial Inc boosted its position in Globe Life by 60.0% in the 2nd quarter. AdvisorNet Financial Inc now owns 224 shares of the company's stock valued at $28,000 after buying an additional 84 shares during the period. CYBER HORNET ETFs LLC purchased a new position in Globe Life in the 2nd quarter valued at approximately $28,000. Assetmark Inc. boosted its position in Globe Life by 777.8% in the 2nd quarter. Assetmark Inc. now owns 237 shares of the company's stock valued at $29,000 after buying an additional 210 shares during the period. Finally, MUFG Securities EMEA plc purchased a new stake in shares of Globe Life during the 2nd quarter worth $31,000. Hedge funds and other institutional investors own 81.61% of the company's stock.

About Representative McClain

Lisa McClain (Republican Party) is a member of the U.S. House, representing Michigan's 9th Congressional District. She assumed office on January 3, 2023. Her current term ends on January 3, 2027. McClain (Republican Party) is running for re-election to the U.S. House to represent Michigan's 9th Congressional District. She declared candidacy for the 2026 election. Lisa McClain lives in Romeo, Michigan. McClain earned a bachelor's degree in business administration from Northwood University. Her career experience includes founding and working as the president of North End Support Team.

Globe Life Company Profile

Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.